2-吡咯烷-1-苯甲腈 | 20925-25-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 中文名称: 2-吡咯烷-1-苯甲腈
• 中文别名: 2-吡咯烷苯甲腈
• 英文名称: 2-(pyrrolidin-1-yl)benzonitrile
• 英文别名: 2-(1-pyrrolidinyl)benzonitrile；2-pyrrolidin-1-ylbenzonitrile
• CAS: 20925-25-1
• 化学式: C₁₁H₁₂N₂
• mdl: MFCD08435870
• 分子量: 172.23
• InChiKey: YUKHVYSSBBOQJW-UHFFFAOYSA-N

物化性质

• 沸点：
  321.5±25.0 °C(Predicted)
• 密度：
  1.12±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  27
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2933990090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Pyrrolidinobenzonitrile
Synonyms: 2-Pyrrolidin-1-ylbenzonitrile

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Pyrrolidinobenzonitrile
CAS number: 20925-25-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H12N2
Molecular weight: 172.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-吡咯烷-1-苯甲腈 在 2-羟基吡啶 、 bis[dichloro(pentamethylcyclopentadienyl)iridium(III)] 、 硫酸 、 溶剂黄146 作用下， 以 2,2,2-三氟乙醇 为溶剂， 反应 122.0h， 生成 2,3-二氢-1H-吡咯并[1,2-A]喹唑啉-5-酮
  参考文献：
  名称：

  通过无受体脱氢偶联有效构建CN双键

  摘要：

  AbstractThe efficient construction of CN double bonds has been achieved by the Ir‐catalyzed intramolecular acceptorless dehydrogenative cross‐coupling of tertiary amines and amides. An iridium/2‐hydroxypyridine complex was identified as the highly efficient catalyst. A number of quinazolinone derivatives was prepared in excellent yields. An iridium‐mediated CH activation mechanism is proposed. This finding provides an unprecedented strategy for the direct imidation of sp3 CH bonds.magnified image

  DOI：

  10.1002/adsc.201300455
• 作为产物：
  描述：

  2-(1-吡咯烷基)苯酚 在 吡啶 、 aluminum (III) chloride 、 bis(1,5-cyclooctadiene)nickel (0) 、 三乙胺 、 4,5-双二苯基膦-9,9-二甲基氧杂蒽 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 反应 2.0h， 生成 2-吡咯烷-1-苯甲腈
  参考文献：
  名称：

  丁腈对镍催化的芳基氯化物和三氟甲磺酸酯的氰化反应：将逆向氢氰化与交叉偶联合并

  摘要：

  我们描述了芳基（假）卤化物的镍催化氰化反应，该反应采用丁腈作为氰化试剂代替剧毒的氰化物盐。将逆向氢氰化和交叉偶联相结合的双催化循环可将多种芳基氯和芳基/乙烯基三氟甲磺酸转化为相应的腈。该新反应为安全制备芳基氰化物提供了战略上独特的方法，芳基氰化物是农业化学和药物化学中必不可少的化合物。

  DOI：

  10.1002/anie.201707517

文献信息

• [EN] FUSED TRICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE<br/>[FR] COMPOSÉS TRYCICLIQUES CONDENSÉS ET UTILISATIONS CORRESPONDANTES EN MÉDECINE
  申请人：SUNSHINE LAKE PHARMA CO LTD

  公开号：WO2018219356A1

  公开（公告）日：2018-12-06

  The present invention relates to a fused tricyclic compound and use thereof as a medicament, in particular as a medicament for the treatment and/or prevention of hepatitis B. Specifically, the invention relates to a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, wherein each variate is as defined in specification. The invention also relates to the use of the compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof as a medicament, especially as a medicament for the treatment and/or prevention of hepatitis B.

  本发明涉及一种融合三环化合物及其作为药物的用途，特别是作为治疗和/或预防乙型肝炎的药物。具体地，本发明涉及具有化学式（I）或其立体异构体、互变异构体、N-氧化物、溶剂合物、代谢物、药学上可接受的盐或其前药的化合物，其中每个变量如规范中所定义。本发明还涉及将具有化学式（I）或其立体异构体、互变异构体、N-氧化物、溶剂合物、代谢物、药学上可接受的盐或其前药用作药物，特别是作为治疗和/或预防乙型肝炎的药物。
• [EN] COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS<br/>[FR] COMPOSÉS ET COMPOSITIONS POUR LEUR UTILISATION DANS LE TRAITEMENT DE TROUBLES CUTANÉS
  申请人：KAMARI PHARMA LTD

  公开号：WO2021154966A1

  公开（公告）日：2021-08-05

  Provided herein is a compound of formula (XXXII) or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer thereof or a physiologically functional derivative thereof, wherein R1, R2, R3, G, A, E, n, p, and q are defined herein. Also provided herein are compositions comprising a compound of formula (XXXII), and methods of using a compound of formula (XXXII), e.g., in the treatment or prevention of skin disorders.

  提供了一种公式（XXXII）的化合物或药用可接受的盐、溶剂化物、水合物、立体异构体或生理功能衍生物，其中R1、R2、R3、G、A、E、n、p和q在此定义。此外，还提供了包含公式（XXXII）化合物的组合物，以及使用公式（XXXII）化合物的方法，例如，在治疗或预防皮肤病中的应用。
• Phosphoryl chloride-mediated solvent-free synthesis of N-aryl-substituted azacycles from arylamines and cyclic ethers
  作者：Van Hieu Tran、Minh Thanh La、Hee-Kwon Kim

  DOI：10.1016/j.tetlet.2019.06.019

  日期：2019.7

  cyclic ethers is described. In this method, the combination of POCl3 and DBU is crucial for conversion of arylamines and cyclic ethers to five- and six-membered azacycles. Without solvent, a variety of N-aryl-substituted, five-membered azacycles (pyrrolidines, 2-methylpyrrolidines, and piperidine) and six-membered azacycles (isoindolines and tetrahydroisoquinolines) are synthesized in high yields. This

  描述了一种用于从芳基胺和环醚制备N-芳基取代的氮杂环化合物的无溶剂和金属方案。在这种方法中，POCl 3和DBU的组合对于将芳胺和环状醚转化为五元和六元氮杂环至关重要。在没有溶剂的情况下，可以高收率合成各种N-芳基取代的五元氮杂环（吡咯烷，2-甲基吡咯烷和哌啶）和六元氮杂环（异吲哚啉和四氢异喹啉）。这种绿色方法为从各种环状醚制备氮杂环化合物提供了一种可持续而有效的方法。
• Selective electrochemical <i>para</i>-thiocyanation of aromatic amines under metal-, oxidant- and exogenous-electrolyte-free conditions
  作者：Ying Zhang、Huanjie Gao、Jiabao Guo、Hao Zhang、Xiaoquan Yao

  DOI：10.1039/d1cc05208j

  日期：——

  An electrochemical oxidative para-C–H-thiocyanation of aromatic amines has been developed to construct thiocyanato aromatic compounds under metal-, oxidant-, and exogenous-electrolyte-free conditions in an undivided cell. The transformation is compatible with a range of primary, secondary, and tertiary amines and shows good functional group tolerance. This approach provides an economical and environmentally

  已开发出芳香胺的电化学氧化对-C - H-硫氰化，以在未分隔的电池中在无金属、无氧化剂和无外源电解质的条件下构建硫氰酸根合芳香族化合物。该转化与一系列伯胺、仲胺和叔胺相容，并显示出良好的官能团耐受性。这种方法为芳香胺的对硫氰化提供了一种经济且环境友好的方法。
• [EN] PYRAZOLO-TRIAZINE AND/OR PYRAZOLO-PYRIMIDINE DERIVATIVES AS SELECTIVE INHIBITOR OF CYCLIN DEPENDENT KINASE<br/>[FR] DÉRIVÉS DE PYRAZOLO-TRIAZINE ET/OU DE PYRAZOLO-PYRIMIDINE EN TANT QU'INHIBITEURS SÉLECTIFS DE KINASE DÉPENDANTE DE LA CYCLINE
  申请人：QURIENT CO LTD

  公开号：WO2019197549A1

  公开（公告）日：2019-10-17

  The present invention relates to pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[l,5-a]pyrimidine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of cell proliferative diseases, inflammatory diseases, immunological diseases, cardiovascular diseases and infectious diseases. Furthermore, the present invention is directed towards pharmaceutical compositions containing at least one of the pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives and/or pharmaceutically acceptable salts thereof.

  本发明涉及吡唑并[1,5-a][1,3,5]三嗪和吡唑[1,5-a]嘧啶衍生物和/或其药用可接受盐，以及这些衍生物作为药用活性剂的用途，特别是用于预防和/或治疗细胞增殖性疾病、炎症性疾病、免疫性疾病、心血管疾病和传染病。此外，本发明还涉及含有至少一种吡唑并[1,5-a][1,3,5]三嗪和吡唑[1,5-a]嘧啶衍生物和/或其药用可接受盐的药物组合物。